CimCure Company
CimCure focuses on design and development of a novel class of active cancer immunotherapies.
Technology:
Peptides and Proteins
Headquarters:
Amsterdam, Noord-Holland, The Netherlands
Investors Number:
1
Total Funding:
79000000
Last Funding Date:
2022-06-07
Last Funding Type:
Seed
Register and Claim Ownership